Warren Buffett's the most famous buy-and-hold investor on the planet, so if his company, Berkshire Hathaway (NYSE:BRK-B) (NYSE:BRK-A), is selling a stock in its portfolio, you might want to consider selling it, too.
Fortunately, Berkshire Hathaway reveals which stocks the Oracle of Omaha is selling in its quarterly 13F filing with the Securities and Exchange Commission. The company's latest filing shows he sold shares in Verisk Analytics, Inc. (NASDAQ:VRSK), IBM (NYSE:IBM), and Phillips 66 (NYSE:PSX). Is it time for these stocks to exit your portfolio, too?
A long relationship ending?When Verisk went public in 2009, Warren Buffett was the only owner not to sell any shares. Clearly, he believed that the long-term opportunity associated with crunching actuarial data for insurers was undervalued in the IPO, but he might not think that anymore.
Image source: The Motley Fool.
Top Warren Buffett Stocks To Watch For 2019: Protalix BioTherapeutics, Inc.(PLX)
Advisors' Opinion:- [By Stephan Byrd]
ILLEGAL ACTIVITY NOTICE: “Protalix Biotherapeutics (PLX) Shares Up 6.8%” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3355139/protalix-biotherapeutics-plx-shares-up-6-8.html.
- [By Ethan Ryder]
PlexCoin (CURRENCY:PLX) traded up 3.9% against the U.S. dollar during the 24-hour period ending at 19:00 PM ET on June 1st. In the last week, PlexCoin has traded down 26% against the U.S. dollar. One PlexCoin token can currently be bought for approximately $0.0095 or 0.00000126 BTC on major exchanges including Cryptopia and CoinExchange. PlexCoin has a total market capitalization of $0.00 and approximately $27.00 worth of PlexCoin was traded on exchanges in the last day.
- [By Stephan Byrd]
PlexCoin (CURRENCY:PLX) traded flat against the US dollar during the 24-hour period ending at 19:00 PM Eastern on August 24th. One PlexCoin token can currently be bought for about $0.0074 or 0.00000111 BTC on popular exchanges. Over the last week, PlexCoin has traded flat against the US dollar. PlexCoin has a total market cap of $0.00 and $7.00 worth of PlexCoin was traded on exchanges in the last 24 hours.
- [By Shane Hupp]
Shares of Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) saw strong trading volume on Wednesday . 3,171,206 shares changed hands during mid-day trading, an increase of 375% from the previous session’s volume of 667,423 shares.The stock last traded at $0.62 and had previously closed at $0.52.
Top Warren Buffett Stocks To Watch For 2019: InfuSystems Holdings, Inc.(INFU)
Advisors' Opinion:- [By Shane Hupp]
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Director Scott Shuda bought 9,548 shares of the company’s stock in a transaction that occurred on Wednesday, September 5th. The stock was acquired at an average price of $3.23 per share, for a total transaction of $30,840.04. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
- [By Logan Wallace]
These are some of the news headlines that may have impacted Accern Sentiment’s scoring:
Get Scynexis alerts: Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) (oracleexaminer.com) Do Analysts Think You Should Buy – SCYNEXIS Inc (NASDAQ: SCYX) (stockspen.com) Notable Runner: SCYNEXIS, Inc. (SCYX) (nasdaqplace.com) Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … (journalfinance.net) Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (stocksnewspoint.com)Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.
- [By Joseph Griffin]
Infusystem Holdings Inc (NYSEAMERICAN:INFU) major shareholder Meridian Ohc Partners, Lp purchased 40,548 shares of Infusystem stock in a transaction dated Monday, May 14th. The shares were acquired at an average cost of $2.76 per share, for a total transaction of $111,912.48. The transaction was disclosed in a filing with the SEC, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
- [By Max Byerly]
LSV Asset Management cut its holdings in InfuSystem Holdings Inc (NYSEAMERICAN:INFU) by 22.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,200 shares of the medical instruments supplier’s stock after selling 36,400 shares during the quarter. LSV Asset Management owned approximately 0.54% of InfuSystem worth $437,000 at the end of the most recent quarter.
Top Warren Buffett Stocks To Watch For 2019: Axcelis Technologies Inc.(ACLS)
Advisors' Opinion:- [By ]
3. Axcelis Technologies (Nasdaq: ACLS)
It is the technical price pattern that first caught my eye with this $800 million market cap small cap. Shares dropped to a $22.00 low in mid-February but have since been slowly and steadily moving higher toward resistance at both the 50- and 200-day SMAs. In and of itself, this is not enough impetus to get long. However, when combined with the fundamental picture, a compelling long thesis emerges. - [By Stephan Byrd]
Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribing]
Axcelis Technologies (NASDAQ:ACLS) Q4 2018 Earnings Conference CallFeb. 7, 2019 8:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
Alps Advisors Inc. raised its stake in shares of Axcelis Technologies Inc (NASDAQ:ACLS) by 13.4% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 20,773 shares of the semiconductor company’s stock after purchasing an additional 2,457 shares during the period. Alps Advisors Inc. owned approximately 0.06% of Axcelis Technologies worth $596,000 as of its most recent SEC filing.
- [By Shane Hupp]
Shares of Axcelis Technologies (NASDAQ:ACLS) have been assigned an average recommendation of “Buy” from the nine analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $30.50.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Warren Buffett Stocks To Watch For 2019: Plexus Corp.(PLXS)
Advisors' Opinion:- [By Shane Hupp]
Plexus Corp. (NASDAQ:PLXS) CAO Angelo Michael Ninivaggi, Jr. sold 6,250 shares of Plexus stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $61.79, for a total value of $386,187.50. Following the completion of the transaction, the chief accounting officer now owns 28,402 shares of the company’s stock, valued at $1,754,959.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Plexus (PLXS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Plexus (PLXS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Warren Buffett Stocks To Watch For 2019: Ascent Capital Group, Inc.(ASCMA)
Advisors' Opinion:- [By Money Morning Staff Reports]
After looking at last week's top performing penny stocks, we'll show you a small-cap stock with real growth potential that just popped up on our radar…
Penny Stock Current Share Price Last Week's Gain New Age Beverage Corp. (NADAQ: NBEV) $3.94 286.79% India Globalization Capital Inc. (NYSE: IGC) $2.18 181.55% Ascent Capital Group Inc. (NASDAQ: ASCMA) $2.16 103.85% Netlist Inc. (NASDAQ: NLST) $0.73 80.56% Oragenics Inc. (NYSE: OGEN) $0.92 71.63% Astrotech Corp. (NASDAQ: ASTC) $3.44 68.37% Command Security Corp. (NYSE: MOC) $2.77 51.09% Oasmia Pharmaceuticals (NASDAQ: OASM) $3.57 50.66% NovaBay Pharmaceuticals Inc. (NYSE: NBY) $2.10 48.15% Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.25 45.72%While the gains these stocks made are exciting, they also highlight the danger of investing in penny stocks.
- [By Shane Hupp]
News stories about Ascent Capital Group Inc Series A (NASDAQ:ASCMA) have trended somewhat negative on Wednesday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ascent Capital Group Inc Series A earned a news sentiment score of -0.02 on Accern’s scale. Accern also assigned news coverage about the industrial products company an impact score of 46.5362897974896 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Ascent Capital Group (ASCMA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Alexander Bird]
Here are the top performers from last week…
Penny Stock Current Share Price Last Week's Gain Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71% Radisys Corp. (Nasdaq: RSYS) $1.55 115.68% Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12% Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63% Tintri Inc. (Nasdaq: TNTR) $0.18 40.49% Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96% Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40% Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40% ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65% SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.
- [By Shane Hupp]
Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.
Top Warren Buffett Stocks To Watch For 2019: Paylocity Holding Corporation(PCTY)
Advisors' Opinion:- [By Logan Wallace]
Paylocity (NASDAQ:PCTY)‘s stock had its “buy” rating reiterated by Robert W. Baird in a research report issued to clients and investors on Friday. They currently have a $68.00 price objective on the software maker’s stock. Robert W. Baird’s price objective would suggest a potential upside of 6.17% from the stock’s current price.
- [By Ethan Ryder]
News articles about Paylocity (NASDAQ:PCTY) have trended somewhat positive this week, according to Accern. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Paylocity earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned press coverage about the software maker an impact score of 45.7246636887572 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
- [By Logan Wallace]
Paylocity Holding (NASDAQ:PCTY) CEO Steven R. Beauchamp sold 80,000 shares of the business’s stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $55.37, for a total value of $4,429,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
- [By Motley Fool Staff]
Paylocity (NASDAQ:PCTY) is looking to change all of that. The company's cloud-based platform was built from the ground up to provide users with an easy-to-use, mobile-focused solution. Paylocity has been grabbing market share away from the industry giants ever since.
- [By Ethan Ryder]
Paylocity (NASDAQ:PCTY) had its target price increased by Stifel Nicolaus from $59.00 to $78.00 in a research note issued to investors on Friday. They currently have a buy rating on the software maker’s stock.
No comments:
Post a Comment